Neuigkeiten | Smiths Medical
Product Announcements and Company News
Weitere Informationen erhalten Sie von unserem Pressekontakt.
- Sicherheitsprodukte für scharfe/spitze InstrumenteWorldwide Notification Regarding the Recall of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe with Skewed Graduation MarkingsSmiths Medical has become aware of specific models and lots of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringes that may exhibit skewed odd number line graduation markings on their syringe barrels.17.06.2021Weitere anzeigen
- BeatmungsgeräteIntroducing the Portex® Acapella® Choice Blue Vibratory Positive Expiratory Pressure (PEP) Therapy System
Smiths Medical announces the launch of the acapella® choice blue vibratory PEP therapy system. Acapella® is designed to aid in the removal of secretions for patients who have Cystic Fibrosis, Chronic Obstructive Pulmonary Disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis.
28.04.2021Weitere anzeigen - InfusionsprodukteSmiths Medical partners with Parkview Health to enhance patient and clinician safetyParkview Health’s integration of the Smiths Medical PharmGuard® Infusion Management System enables smart pump programming and auto documentation to improve safety.14.04.2021Weitere anzeigen
- InfusionsprodukteECRI Evaluation of CADD®-Solis V4 Wireless Ambulatory Infusion SystemThe report highlights ECRI’s evaluation ratings, test results, and purchasing recommendations for the CADD®-Solis pump.30.03.2021Weitere anzeigen
- Produkte für das SchmerzmanagementLaunch of Portex® EchoGlo® Peripheral Nerve Block PortfolioSmiths Medical, a leading medical device manufacturer, is excited to announce the launch of its EchoGlo® peripheral nerve block portfolio. This addition to the Portex® portfolio of pain management products offers customers a complete solution for regional anesthesia from pump to patient.14.12.2020Weitere anzeigen
- InfusionsprodukteCADD®-Solis Wireless Communication - Cybersecurity Bulletin
Smiths Medical is aware of, and currently monitoring, the Cybersecurity and Infrastructure Security Agency (CISA) notification concerning the Cybersecurity Vulnerability, ICSA-20-168-011 (the “Advisory”).
20.11.2020Weitere anzeigen - InfusionsprodukteDas Smiths Medical Schmerz-Management System mit drahtloser KommunikationSmiths Medical, ein führendes, globales MedTech Unternehmen, hat eine neue Version der CADD®-Solis Pumpe, die CADD Solis V4.2 herausgebracht und damit weltweit eine Grundlage für die drahtlose Kommunikation in der Infusionstherapie geschaffen.27.10.2020Weitere anzeigen
- InfusionsprodukteWorldwide Notification Regarding Potential for Inappropriate Bolus or Loading Dose Delivery in Certain Medfusion® 3500 and 4000 Infusion PumpsDue to a software error, if a bolus or loading dose is interrupted and a specific sequence of events occurs, over- or under-delivery of a bolus or loading dose may occur.19.08.2020Weitere anzeigen
- Sicherheitsprodukte für scharfe/spitze InstrumenteSmiths Medical partners with U.S. government on COVID-19 vaccine effortsThe partnership with BARDA and JPEO-CBRND includes a $20 million investment for increased syringe and needle device production to support Operation Warp Speed vaccine program.15.07.2020Weitere anzeigen
- InfusionsprodukteSmiths Medical Cybersecurity Bulletin
Smiths Medical is aware of, and currently monitoring, the Cybersecurity and Infrastructure Security Agency (CISA) notification concerning the Cybersecurity Vulnerability, ICSA-20-168-01
02.07.2020Weitere anzeigen - InfusionsprodukteNo Smiths Medical products affected by FDA and CISA "URGENT/11" vulnerabilities
The FDA and CISA announced a set of cybersecurity vulnerabilities referred to as "URGENT/11" that have the potential to introduce risks to certain medical devices or hospital networks.
16.10.2019Weitere anzeigen - InfusionsprodukteSmith Medical announces first hospital to implement smart pump programming with the Medfusion® 4000 wireless syringe pump and PharmGuard® infusion management system
Smart pump programming will allow the Medfusion® 4000 pumps to be programmed based on the clinician order, minimizing programming errors.
17.09.2019Weitere anzeigen